Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
AMG-193 by Amgen for Metastatic Biliary Tract Cancer: Likelihood of Approval
AMG-193 is under clinical development by Amgen and currently in Phase II for Metastatic Biliary Tract Cancer. According to GlobalData,...
Data Insights
AMG-193 by Amgen for Metastatic Biliary Tract Cancer: Likelihood of Approval
AMG-193 is under clinical development by Amgen and currently in Phase II for Metastatic Biliary Tract Cancer. According to GlobalData,...